Hospital Acquired Infection Testing Market to achieve USD 1,265 Million by 2020 Owing to I

According to a market research report published by iHealthcareAnalyst, Inc., Hospital Acquired Infection Testing Market – Global Disease Testing Methods Analysis and Forecast 2013-2020, the global hospital acquired infection testingmarketwas valued at USD 564 Million in 2015 and is estimated to reach USD 1,265 Million by 2020, at a CAGR of 17.5% from 2016 to 2020.

Browse the Hospital Acquired Infection Testing Market – Global Disease Testing Methods Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/hospital-infection-therapeutics-market/     

Hospital-acquired infection (HAI) or nosocomial infection can be contracted from the environment or staff of a healthcare facility. It can be spread in the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings. The hospital acquired infection testingmarket report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (blood stream associated infection, MRSA infection, Hospital-acquired pneumonia, surgical associated infection, UTI, Gastroenteritis, puerperal fever, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global hospital acquired infection testing market is segmented as:

1.      Infection Type

1.1.    Blood Stream Associated Infection

1.2.   Methicillin-resistant Staphylococcus aureus (MRSA) infection

1.3.   Hospital Acquired Pneumonia

1.4.   Surgical Associated Infection

1.5.   Urinary Tract Infection (UTI)

1.6.   Others

2.     Geography (Region, Country)

2.1.   North America (U.S., Canada)

2.2.  Latin America (Brazil, Mexico, Rest of LA)

2.3.  Europe (U.K., Germany, France, Italy, Spain, Rest of EU)

2.4.  Asia Pacific (Japan, China, India, Rest of APAC)

2.5.  Rest of the World

3.     Company Profiles

3.1.   Abbott Laboratories

3.2.  Alere, Inc.

3.3.  Becton, Dickinson and Company

3.4.  bioMérieux SA

3.5.  Cepheid, Inc.

3.6.  Diatherix Laboratories, Inc.

3.7.  F. Hoffmann-La Roche Ltd.

3.8.Hologic, Inc.

3.9.  Meridian Bioscience, Inc.

3.10.                   Qiagen

3.11.                     Siemens Healthcare

3.12.                    Thermo Fisher Scientific, Inc. (Life Technologies Corp.)

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.